WINDTREE THERAPEUTICS INC /DE/ Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $86K, a 71.8% decline year-over-year.
  • Windtree Therapeutics Inc /De/ Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $740K, a 58% decline year-over-year.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2023 was $1.28M, a 58.6% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2022 was $3.09M, a 57.4% decline from 2021.
  • Windtree Therapeutics Inc /De/ annual Share-based Payment Arrangement, Expense for 2021 was $7.24M, a 27.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $740K $86K -$219K -71.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-26
Q2 2024 $959K $97K -$285K -74.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $1.24M $251K -$34K -11.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.28M $306K -$485K -61.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $1.76M $305K -$439K -59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-26
Q2 2023 $2.2M $382K -$399K -51.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $2.6M $285K -$485K -63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.09M $791K -$831K -51.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $3.92M $744K -$885K -54.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.8M $781K -$763K -49.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $5.57M $770K -$1.67M -68.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $7.24M $1.62M +$341K +26.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $6.9M $1.63M +$481K +41.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.42M $1.54M -$22K -1.41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6.44M $2.44M +$754K +44.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.68M $1.28M -$232K -15.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $5.92M $1.15M -$791K -40.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $6.71M $1.57M -$173K -9.95% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6.88M $1.69M +$159K +10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $6.72M $1.51M +$1.26M +500% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $5.46M $1.94M +$1.79M +1237% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $3.67M $1.74M +$1.6M +1142% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $2.07M $1.53M +$1.11M +266% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $955K $252K -$577K -69.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-03
Q3 2018 $1.53M $145K -$33K -18.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.57M $140K -$114K -44.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.68M $418K +$118K +39.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 $1.56M $829K +$532K +179% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-23
Q3 2017 $1.03M $178K -$95K -34.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.12M $254K +$4K +1.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.12M $300K -$303K -50.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $1.42M $297K -$47K -13.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $1.47M $273K -$145K -34.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.62M $250K -$85K -25.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $1.7M $603K +$4K +0.67% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.7M $344K -$256K -42.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $1.95M $418K -$439K -51.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $2.39M $335K -$446K -57.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.84M $599K -$104K -14.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $2.94M $600K -$6K -0.99% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-03-29
Q3 2014 $2.95M $857K +$216K +33.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $2.73M $781K +$174K +28.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.56M $703K +$347K +97.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.21M $606K -$527K -46.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $2.74M $641K +$167K +35.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $2.57M $607K +$201K +49.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.37M $356K -$42K -10.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $2.41M $1.13M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $474K +$326K +220% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $406K +$223K +122% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $398K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q3 2011 $148K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $183K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.